INGN Q2 2024 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$89M+6.1% YoY

Gross Profit

$43M48.1% margin

Operating Income

-$7M-8.0% margin

Net Income

-$6M-6.3% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+13.8%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$309M

Total Liabilities

$121M

Stockholders' Equity

$188M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$84M	+6.1%
Gross Profit	$43M	$34M	+25.5%
Operating Income	-$7M	-$12M	+40.0%
Net Income	-$6M	-$10M	+43.1%

Geographic Segments

UNITED STATES

$58M66%

Non-US

$31M34%